期刊文献+

胃癌化疗相关基因的研究进展

Gastric cancer chemotherapy related genes
原文传递
导出
摘要 基因的表达对胃癌的药物治疗有着十分重要的影响,有的基因与药物的疗效相关,有的基因与药物的不良反应相关,而有的基因则与肿瘤对药物的敏感性相关。胃癌化疗相关基因的研究对提高患者化疗疗效有着重要的指导作用。近年来对胃癌化疗相关基因的研究取得了较大进展,特别是在铂类、嘧啶类、紫杉醇类以及靶向药物相关基因的研究。 The expression of genes have an important effect to gastric cancer chemotherapy. Some genes are related the therapeutic efficacy of drugs, some genes are related the untoward effects of drug, and some genes are related the sensitivity of the tumor to drug. Chemotherapy related genes may play an important guiding role to improve the curative effect of chemotherapy patients. In recent years, the gastric cancer chemo- therapy related genes have made great progress, especially in platinum, fluorouracil, paclitaxel and targeted medicine related genes.
作者 覃勇 郭红
出处 《国际肿瘤学杂志》 CAS 2012年第7期533-537,共5页 Journal of International Oncology
关键词 胃肿瘤 药物疗法 基因表达 Stomach neoplasms Drug therapy Gene expression
  • 相关文献

二级参考文献24

  • 1Kang YK,Kang WK,Shin DB, et al.Capecitabine/cisplatin versus 5‐fluorouracil/cisplatin as first‐line therapy in patients with advanced gastric cancer: a randomised phase III noninferioritytrial. Annals of Oncology . 2009
  • 2Puglisi F,Cardellino GG,Crivellari D, et al.Thymidine phosphorylase expression is associated with time to progression in patient receiving low dose, docetaxel‐modulated capecitabine for metastatic breast cancer. Annals of Oncology . 2008
  • 3Napieralski R,Ott K,Kremer M, et al.Combined GADD45A and thymidine phosphorylase expression levels predict response and survival of neoadjuvant treated gastric cancer patients. Clinical Cancer Research . 2005
  • 4Ichikawa W,Takahashi T,Suto K et al.Gene expressions for thymidylate synthase (TS), orotate phosphoribosyltransferase(OPRT), and thymidine phosphorylase (TP), not dihydro‐ pyrimidine dehydrogenase (DPD), influence outcome of patients (pts) treated with S‐1 for gastric cancer (GC). Journal of Clinical Oncology . 2004
  • 5Rosell R,Scagliotti G,Danenberg KD, et al.Transcripts in pretreatment biopsies from a three‐arm randomized trial in metastatic non‐small‐cell lung cancer. Oncegene . 2003
  • 6Dumontet C,Isaac S,Souquet PJ, et al.Expression of class III beta tubulin in non‐small cell lung cancer is correlated with resistance to taxane chemotherapy. Bulletin du Cancer . 2005
  • 7Urano N,Fujiwara Y,Doki Y, et al.Clinical significance of class III beta‐tubulin expression and its predictive value for resistance to docetaxel‐based chemotherapy in gastric cancer. International Journal of Oncology . 2006
  • 8Kwon HC,Roh MS,Oh SY, et al.Prognostic value of expression of ERCC1, thymidylate synth‐ ase, and glutathione S‐transferase P1 for 5‐fluorouracil/oxaliplatin chemotherapy in advanced gastric cancer. Annals of Oncology . 2007
  • 9Bernard-Marty,C,Treilleux,I,Dumontet,C.Microtubule-Associated Parameters as Predictive Markers of Docetaxel Activity in Advanced Breast Cancer Patients: Results of a Pilot Study. Clinical Breast Cancer . 2002
  • 10Ferrandina,G.et al.Class Ⅲ beta-tubulin overexpression is a marker of poor clinical outcome in advanced ovarian cancer patients. Clinical Cancer Research . 2006

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部